Get my own profile
Public access
View all3 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Michael O'NeillHead of Molecular Pathology, Eli Lilly & Co. Ltd.Verified email at lilly.com
- Fiona MarshallPresident Biomedical Research NovartisVerified email at novartis.com
- Mark WigglesworthAlderley Lighthouse LabsVerified email at alderleylighthouselabs.com
- Michel GoedertMRC Laboratory of Molecular Biology, Cambridge, UKVerified email at mrc-lmb.cam.ac.uk
- Samuel JacksonUK Dementia Research InstituteVerified email at ukdri.ac.uk
- Graeme MilliganUniversity of GlasgowVerified email at glasgow.ac.uk
- Adrian IsaacsUCL Institute of NeurologyVerified email at ucl.ac.uk
- Chris LangmeadMonash UniversityVerified email at monash.edu
- Abdel EnnaceurSenior Lecturer in Pharmacology, University of Sunderland, UKVerified email at sunderland.ac.uk
- Joanna HolbrookCSO, Cambridge EpigenetixVerified email at cegx.co.uk
- Ganesh SatheGlaxoSmithKlineVerified email at gsk.com
- Berthold WroblowskiSenior scientist,Janssen, Pharmaceutical Companies of Johnson and JohnsonVerified email at its.jnj.com
- Stephen L GarlandNQuiX LtdVerified email at nquix.com
- adrian hallucbVerified email at ucb.com
- Michael PoidingerAd-hoc consultant
- Jim J HaganNeuroscience Consultant